JBJS Endorses Concerns Regarding Speculative Commercial Cell-Banking Services
- PMID: 31880657
- DOI: 10.2106/JBJS.19.01268
JBJS Endorses Concerns Regarding Speculative Commercial Cell-Banking Services
References
-
- U.S. Food and Drug Administration. FDA warns US stem cell clinic of significant deviations. 2017 Aug 28. Accessed 2019 Oct 25. https://www.fda.gov/news-events/press-announcements/fda-warns-us-stem-ce...
-
- U.S. Food and Drug Administration. FDA acts to remove unproven, potentially harmful treatment used in ‘stem cell’ centers targeting vulnerable patients. 2017 Aug 28. Accessed 2019 Oct 25. https://www.fda.gov/news-events/press-announcements/fda-acts-remove-unpr...
-
- International Society for Cell and Gene Therapy. ISCT issues patient advice and concern on unproven T-cell preservation services. 2019 Aug 7. Accessed 2019 Oct 25. https://isctglobal.org/news/464648/ISCT-issues-patient-advice-and-concer...
-
- International Society for Cell and Gene Therapy. ISCT statement of concern regarding speculative commercial cell banking services. Accessed 2019 Oct 25. https://isctglobal.org/news/474457/ISCT-Statement-of-Concern-Regarding-S...
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources